WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

KEGG Spider: Interpretation of Genomics Data in the Context of the Global Gene

Details
Research
09 January 2009
Scientists from Helmholtz Zentrum München have developed a breakthrough methodology for understanding metabolism related variations from experimental genomics data. Using proposed bioinformatics strategy they were able to demonstrate that in most cases identified disease-specific metabolism variations are not independent, e.g. deregulated genes from different pathways are linked to each other via one or two step of consecutive metabolic reactions.
Read more ...

Complimentary white paper to help marketers stay ahead of the digital marketing curve

Details
Research
09 January 2009
Manhattan ResearchThe new year was ushered in amidst economic uncertainties and the impending inauguration of a new administration - the effects of which have great implications for the pharmaceutical industry. Brand managers especially will feel the heat as marketing spend and measurement is increasingly scrutinized. But despite the doom and gloom in predictions for the year ahead, physicians and patients will continue to use healthcare products and services and companies still need to find ways to effectively reach their target audiences.
Read more ...

Study sheds new light on aggressive childhood cancer

Details
Research
07 January 2009
EU-funded researchers have uncovered some of the complex molecular mechanisms that drive the growth of neuroblastoma, a type of cancer found in very young children. The scientists hope that their findings, published in the journal Cancer Cell, will lead to the development of new therapies to treat this often aggressive and unpredictable disease.
Read more ...

PharmaNews.eu - Dynamic European Pharmaceutical News Engine

Details
Research
06 January 2009
PharmaNews.eu, an advanced web based news project targeting the European pharmaceutical domain, has been launched. The project was developed to directly connect, promote and disseminate the European Industry and Research pharmaceutical achievements with additional focus on the European Commission (EC) and European Medicines Agency (EMEA) news.
Read more ...

Healthcare Costs Prevented Almost 40 Million Americans from Filling Their Prescriptions in 2008

Details
Research
19 December 2008
Manhattan ResearchNearly 40 million U.S. adults decided not to fill a prescription medication from a doctor in the past year because of the cost, according to pharmaceutical and healthcare market research company Manhattan Research’s Cybercitizen Health™ v8.0 consumer study and strategic advisory service.
Read more ...

New semantics in GoPubMed and European biotech start-ups

Details
Research
18 December 2008
Transinsight has announced the launch of GoPubMed.com version 4.0, the semantic search engine for the life sciences with significantly improved features.
  • Increased Speed: GoPubMed 4.0 is ten times faster than its predecessor, now handling millions of documents in seconds.
Read more ...

Metabolic disturbances indicate progress of the disease even years in advance

Details
Research
17 December 2008
Finnish scientists have reported a breakthrough in the attempts to understand the development of type 1 diabetes. They discovered disturbances in lipid and amino acid metabolism in children who later progressed to type 1 diabetes, also known as juvenile diabetes. The alterations preceded the autoimmune response by months to years.
Read more ...

More Pharma News ...

  1. Expert System for Automatic Analysis of Data Quality in Clinical Trials
  2. Strengthening pharmacovigilance to reduce adverse effects of medicines
  3. Innovators from Global Biopharma Companies Discuss Consumer & Physician E-marketing Trends
  4. New discovery: lethal fungus reproduces sexually
  5. New mouse model for study of Creutzfeldt-Jakob disease
  6. UK's Government and Industry in drug price deal
  7. Manhattan Research Releases Report on the Future of Physician Customer Service Portals
  • Start
  • Prev
  • 289
  • 290
  • 291
  • 292
  • 293
  • 294
  • 295
  • 296
  • 297
  • 298
  • Next
  • End
Tahmeena

Business & Industry

  • Pfizer reports record full-year 2022 results
  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries

Research & Development

  • Scientists pinpoint protein that helps cancer-causing viruses evade immune response
  • Transforming the way cancer vaccines are designed and made
  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research
  4. Scientists pinpoint protein that helps cancer-causing viruses evade immune response

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.